market access

News

UK shows lead in real-world research after lung trial succes...

The UK is positioning itself as a one-stop shop for clinical research, following a ground-breaking respiratory "real world" study undertaken by GSK.

Articles

The superbug battle: O'Neill plan meets its own resistance f...

suggestions that pharma should be levied to pay for a global fund have met their own resistance.

Articles

The UK pharma market – Accelerating Access or still stuck in...

Hundreds of novel medicines are expected to gain approval between 2016 and 2020 but will the NHS make the most of the best new drugs, or limit access and uptake as in previous years?

Articles

Germany and the pharma industry: seeing eye to eye at last?

Germany is the third-largest drug market in the world – and the biggest in Europe – but its cost-containment measures in recent years have seen some pharma companies opt out of launching medici

Articles

Accelerating health technologies with NICE Office for Market...

England's health watchdog launched its service to speed the delivery of new technologies in October 2015.

Views & Analysis

Healthcare opportunities in Latin America

This first article in a three-part series sets the scene for healthcare trends in Latin America and covers the impact of currency devaluations, corruption and public-private partnerships (PPPs)

UK shows lead in real-world research after lung trial succes...

The superbug battle: O'Neill plan meets its own resistance f...

The UK pharma market – Accelerating Access or still stuck in...

Germany and the pharma industry: seeing eye to eye at last?

Accelerating health technologies with NICE Office for Market...

Healthcare opportunities in Latin America

GBL joins CVC in €10.7bn takeover bid for Recordati

Discover a new era of healthcare panel engagement: Grounded ...

market access

Editor's Picks